USAID, the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada, DFID, and KOICA have joined together to launch Saving Lives at Birth: A Grand Challenge for Development, to find the tools and approaches to help the mothers and newborns during their most vulnerable hours.
We seek groundbreaking prevention and treatment approaches for pregnant women and newborns in poor, hard-to-reach communities around the time of delivery.
This is the period when the majority of maternal and newborn deaths occur and the population that has been the most difficult to reach.
We seek innovative ideas that can leapfrog conventional approaches in three main domains: (1) technology; (2) service delivery; and (3) “demand side” innovation that empowers pregnant women and their families to practice healthy behaviors and be aware of and access health care during pregnancy, childbirth and the early postnatal period, especially the first two days after birth.
Significant breakthroughs in innovation often come about when new ideas and disciplines are applied to long-entrenched problems. New technologies and approaches transform insurmountable development challenges into solvable problems. To harness this ingenuity, we encourage partnerships that bring together diverse expertise from non-traditional partners. And to foster sustainability, we encourage the private sector to bring their expertise and experience to bear on these problems.
How It Works
Six partners - USAID, the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada, DFID, and KOICA - came together to support this single challenge. The World Bank is also an affiliate of this program. Projects will be jointly selected through a unified application process. Successful innovators will be managed independently by one of two partners and funded and supported collectively as a community of innovators by all six partners.
Building a Community of Innovators
Partners will work with this community to foster learning and continued innovation. Awardees will receive support and networking assistance from each of the partners, engage with other innovators, and participate in high-level meetings including the Bill & Melinda Gates Foundation’s annual Grand Challenge meetings.
Types of Awards
We will invest in a portfolio of projects. Through this portfolio, we will seek groundbreaking innovations by providing:
Seed Funds to support the development and validation of ideas capable of impacting health outcomes for pregnant women and their babies in low-resource settings,
Validation Funds to introduce and validate the effectiveness of innovations to reach proof-of-concept, and
Transition to Scale Funds to develop, refine, and rigoursly test the impact of integrated solutions that have previously measured promising health outcomes in a controlled or limited setting and have the potential to credibly scale to improve the lives of millions of pregnant women and newborns in multiple countries. Transition funding is limited to integrated solutions that unite technology, service delivery, and demand.
A brief application.
Rapid turnaround time. We aim to select awards within 5 months from the proposal submission deadline.
Opportunities for shared learning and collaboration among innovators, funders and other public health experts.
A review process designed to identify potentially groundbreaking ideas that show great promise.
What We’re Looking For
Substantially increase demand for and access to primary health interventions for women and newborns (for example, by at least 50 percent for interventions with low coverage);
Substantially improve the quality of care as measured by health outcomes; and
Improve and sustain healthy behavior.
Be "off the beaten track," daring in premise, and clearly differentiated from standard practice;
Enhance uptake, acceptability and provide for sustained use (potential for sustainability as defined as cost-recovery, sustained use, and sustainable impact);
Be low-cost or highly cost-effective solutions;
Have a strong likelihood of achieving a substantial impact on one or more important adverse maternal, fetal, or neonatal health conditions;
Be scalable in resource-poor settings;
Be able to be monitored, measured and evaluated.